BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-15.26%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.26B
AUM Growth
+$1.26B
(-22%)
Cap. Flow
+$62M
Cap. Flow
% of AUM
4.92%
Top 10 Holdings %
Top 10 Hldgs %
73.34%
Holding
36
New
3
Increased
5
Reduced
3
Closed
2
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$68.2M |
| 2 |
Xilio Therapeutics
XLO
|
$44.9M |
| 3 |
Mersana Therapeutics
MRSN
|
$10.5M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
$9.94M |
| 5 |
TSVT
2seventy bio
TSVT
|
$4.6M |
Top Sells
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$62.1M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$10.9M |
| 3 |
Invivyd
IVVD
|
$3.99M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$2.49M |
| 5 |
Nurix Therapeutics
NRIX
|
$29 |
Sector Composition
| 1 | Healthcare | 95.4% |
| 2 | Financials | 3.02% |
